SEC Form 4/A · accession 0001171843-15-000870
TETRALOGIC PHARMACEUTICALS Corp · TLOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Colin Glenn Begley
Officer — Chief Scientific Officer & SVP
Period of report
Dec 10, 2014
Accepted (ET)
Feb 17, 2015 · 3:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001361248
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock - Colin Glenn BegleyF1 | Dec 10, 2014 | P | 6,000 | $6.16 | A | 198,234 | D | |
| Common Stock - Ryan Alexander Begley (Son)F2 | holding | — | — | — | 1,100 | I | By family member |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The total amount of securities purchased on 12/10/2014 was inadvertently under-reported by 100 shares and therefore has been revised from 5,900 shares to 6,000 shares.
- F2Reported when acquired and inadvertently omitted from Section 5 on Form 4 filed on 12/12/2014.